CLSD Clearside Biomedical Net earnings per share (EPS TTM)

Clearside Biomedical Inc (CLSD) - corporate logo

Clearside Biomedical is recognized as an expert in innovative drug delivery methods to the posterior segment of the eye. Business efficiency is supported by a precise micro-injection transport system, which ensures raw material integrity and high margins. Physician confidence in suprachoroidal technology confirms the brand's scientific potential. The rolling annual EPS trend demonstrates profit dynamics, where -5.03 represents the latest metric reading.

CLSD Clearside Corp Net earnings per share for the last four quarters (07/04/2022 - 12/13/2025)

Clearside Biomedical Inc - analytical breakdowns and key metrics (CLSD)

- share price and expert price forecast:
Stock Quotes Clearside Biomedical|CLSD - Average Forecast Price
- market capitalization data:
Market Capitalization Clearside Biomedical, Inc.|CLSD - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Clearside Biomedical|CLSD - Book Valuation of Business|Market Capitalization to Book Value Ratio clearsidebio.com|CLSD - Cumulative Company Assets
- debt and liquidity details:
Debt to Equity Clearside Biomedical|CLSD - Long-Term Debt to Equity|Short-Term Debt to Capital Clearside|CLSD - Company Cumulative Debt|Debts to Book Capitalization Clearside Biomedical, Inc.|CLSD - Company Long-Term Debts|Company Short-Term Debt Clearside Biomedical|Quick Liquidity clearsidebio.com
- earnings and multiples data:
CLSD - Net Financial Result|Projected Future Earnings Clearside Biomedical|CLSD - Business Payback Period|Forward P/E Multiple Clearside Biomedical, Inc.|CLSD - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Clearside Biomedical, Inc.|CLSD - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Clearside Biomedical|CLSD - Earnings per share for the trailing year|Quarterly EPS earnings growth clearsidebio.com|CLSD - Earnings per share growth in current year|Earnings growth forecast for next year Clearside Biomedical
Basic company analysis:Clearside Biomedical (CLSD)
Mass-produced product of Clearside Biomedical Inc

Net income per share (TTM) reflects the company's annual earnings per unit, adjusted for the total number of outstanding securities. Investors utilize this metric to decouple fundamental growth from short-term market speculation. By analyzing changes in the rolling annual EPS, one can assess the actual efficiency of profit generation. For Clearside Biomedical (CLSD), this indicator is critical when scaling sales of the SCS micro-injector. The trend of this metric confirms the financial stability of the retinal drug delivery technology.

Competitors of Clearside Biomedical (CLSD)

ALC: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months bausch.com|GKOS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Apellis Pharmaceuticals, Inc. (APLS)|Earnings per share for the last twelve months Belite Bio, Inc|Ocular Pharma (OCUL) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HROW|Net earnings per share for the last 12 months viridiantherapeutics.com VRDN|Earnings per share for the last twelve months LENZ Therapeutics LENZ|Oculis AG - Earnings per share for the last twelve months|EyePoint Pharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Kodiak Corp|ALDX: Net earnings per share (EPS TTM)|KALA BIO (KALA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Opus Genetics, Inc.|OKYO: Earnings per share for the trailing year|Earnings per share for the last twelve months Adverum Biotechnologies (ADVM)|Net earnings per share for the last four quarters Outlook Therapeutics Corp|Net earnings per share (EPS TTM) NBY (NovaBay Pharmaceuticals, Inc.)|Net earnings per share for the last four quarters Kiora Pharmaceuticals Inc. (KPRX)|Alimera - Net earnings per share (EPS TTM)|EYEN (Eyenovia, Inc.) - Earnings per share for the last 12 months|GHSI: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ocuphire Corporation (OCUP)|Net earnings per share for the last 12 months OPT